Bicara Therapeutics Inc. Common Stock (BCAX)
BCAX Stock Price Chart
Explore Bicara Therapeutics Inc. Common Stock interactive price chart. Choose custom timeframes to analyze BCAX price movements and trends.
BCAX Company Profile
Discover essential business fundamentals and corporate details for Bicara Therapeutics Inc. Common Stock (BCAX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Sept 2024
Employees
55.00
Website
https://www.bicara.comCEO
Claire Mazumdar Clemon
Description
Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously engaging the epidermal growth factor receptor (EGFR) and binding to human transforming growth factor beta (TGF-b). Bicara Therapeutics operates as a subsidiary of Biocon Limited.
BCAX Financial Timeline
Browse a chronological timeline of Bicara Therapeutics Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.82.
Earnings released on 11 May 2026
EPS came in at -$0.93 falling short of the estimated -$0.64 by -45.31%.
Earnings released on 26 Mar 2026
EPS came in at -$0.68 surpassing the estimated -$0.72 by +5.56%.
Earnings released on 10 Nov 2025
EPS came in at -$0.67 falling short of the estimated -$0.55 by -21.82%.
Earnings released on 12 Aug 2025
EPS came in at -$0.50 surpassing the estimated -$0.54 by +7.41%.
Earnings released on 13 May 2025
EPS came in at -$0.68 falling short of the estimated -$0.40 by -70.00%.
Earnings released on 27 Mar 2025
EPS came in at -$0.39 falling short of the estimated -$0.31 by -25.81%.
Earnings released on 12 Nov 2024
EPS came in at -$1.60 falling short of the estimated -$0.46 by -247.83%.
Earnings released on 13 Sept 2024
EPS came in at -$0.27 .
Earnings released on 30 Jun 2024
EPS came in at -$0.27 .
Earnings released on 31 Dec 2023
EPS came in at -$0.23 .
Earnings released on 30 Sept 2023
EPS came in at -$0.42 .
Earnings released on 30 Jun 2023
EPS came in at -$0.15 .
Earnings released on 31 Mar 2023
EPS came in at -$0.15 .
BCAX Stock Performance
Access detailed BCAX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
